WO2025247187 - USE OF ANTI-TROP2 ANTIBODY-DRUG CONJUGATE IN COMBINATION WITH ANTI-PD-L1/CD47 BISPECIFIC ANTIBODY FOR TREATING TUMORS
National phase entry is expected:
Publication Number
WO/2025/247187
Publication Date
04.12.2025
International Application No.
PCT/CN2025/097338
International Filing Date
27.05.2025
Title **
[English]
USE OF ANTI-TROP2 ANTIBODY-DRUG CONJUGATE IN COMBINATION WITH ANTI-PD-L1/CD47 BISPECIFIC ANTIBODY FOR TREATING TUMORS
[French]
UTILISATION D'UN CONJUGUÉ ANTICORPS-MÉDICAMENT ANTI-TROP2 EN COMBINAISON AVEC UN ANTICORPS BISPÉCIFIQUE ANTI-PD-L1/CD47 POUR LE TRAITEMENT DE TUMEURS
[Chinese]
抗TROP2抗体药物偶联物和抗PD-L1/CD47双特异抗体联合治疗肿瘤的用途
Applicants **
BIO-THERA SOLUTIONS, LTD.
Inventors
WANG, Hao
SONG, Shuqiang
Priority Data
202410667984.2
27.05.2024
CN
Application details
| Total Number of Claims/PCT | * |
| Number of Independent Claims | * |
| Number of Priorities | * |
| Number of Multi-Dependent Claims | * |
| Number of Drawings | * |
| Pages for Publication | * |
| Number of Pages with Drawings | * |
| Pages of Specification | * |
| * | |
| Number of Office Actions | * |
| * | |
International Searching Authority |
CNIPA
* |
| Recordal of a Change of the Applicant's Name/Address |
Change of Applicant's Name and Address
* |
| Type of Assignment |
The Standard Agent's Assignment
* |
| Applicant's Legal Status |
Legal Entity
* |
| * | |
| * | |
| * | |
| * | |
| * | |
| Entry into National Phase under |
Chapter I
* |
| Patent Delivery |
Send the Letters Patent by Courier
* |
| Translation |
|
* The data is based on automatic recognition. Please verify and amend if necessary.
** IP-Coster compiles data from publicly available sources. If this data includes your personal information, you can contact us to request its removal.
Quotation for National Phase entry
| Country | Stages | Total | |
|---|---|---|---|
| China | Filing, Examination, Granting | 2284 | |
| EPO | Filing, Examination, Granting | 20097 | |
| Japan | Filing, Examination, Granting | 2647 | |
| South Korea | Filing, Examination, Granting | 3192 | |
| USA | Filing, Examination, Granting | 6940 |
Total:
35,160
Contact Us
Abstract[English]
The present invention relates to a method of using or a use of an anti-TROP2 antibody-drug conjugate in combination with an anti-PD-L1/CD47 bispecific antibody or an antigen-binding fragment for treating tumors.[French]
La présente invention concerne une méthode d'utilisation ou une utilisation d'un conjugué anticorps-médicament anti-TROP2 en combinaison avec un anticorps bispécifique anti-PD-L1/CD47 ou un fragment de liaison à l'antigène pour le traitement de tumeurs.[Chinese]
本发明涉及抗TROP2抗体药物偶联物和抗PD-L1/CD47双特异抗体或抗原结合片段联合用于治疗肿瘤的方法或用途。